Dihydropyrimidinase‐like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia
Work
Year: 2023
Type: article
Abstract: Background Identifying therapeutic targets and prognostic biomarkers significantly contributes to individualized treatment of acute myeloid leukemia (AML). Dihydropyrimidinase‐like 2 (DPYSL2) express... more
Source: Cancer Medicine
Institutions Zhejiang University, First Affiliated Hospital Zhejiang University, Ningbo University, Zhejiang Cancer Hospital
Cites: 42
Cited by: 7
Related to: 10
FWCI: 3.578
Citation percentile (by year/subfield): 99.99
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
APC paid (est): $3,025